YOLFTbeta
MDxHealth SA

MDxHealth SA

MDXH · NASDAQ · Healthcare / Diagnostics & Research

0.1441USD+0.00 (+2.93%)

Price History

Full chart

Market Stats

Previous Close0.14
Open0.14
Day Range0.1128 – 0.145
52-Week Range0.40 – 5.33
Volume2.00M
Market Cap53.93M
P/E (TTM)0.00
Forward P/E27.70
EPS-0.71
Dividend Yield0.00%
Beta-501643.70
50-Day Avg0.592
200-Day Avg1.91

About

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. It offers genomic prostate score, which provides personalized genomic insights to physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. The company sells its products through urology sales force consisting of direct sales representatives, strategic account managers, and regional sales managers. The company has a collaboration the initiation of Genomic Prostate Score (GPS) testing. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Michael K. McGarrity
  • Employees364
  • HeadquartersCAP Business Center, Herstal, Belgium, 4040, USA
  • Websitehttps://mdxhealth.com

Leadership

  • Mr. Michael K. McGarrityCEO & Executive Director · b. 1963
  • Mr. Ron Kalfus CPAInterim Chief Financial Officer · b. 1974
  • Mr. Joseph Sollee J.D., LLMExecutive VP of Corporate Development & General Counsel · b. 1965
  • Mr. John A. BellanoChief Commercial Officer · b. 1969
  • Mr. Scott McMahanVice President of Finance & Accounting
  • Ms. Kim LerouxExecutive Vice President of Revenue Cycle Management

Financials

Income Statement

Currency: USD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue525.97K3.65M3.66M3.85M4.21M3.65M3.37M3.48M4.92M7.55M11.48M17.47M29.87M40.51M28.34M11.79M18.46M22.24M37.05M70.19M90.05M107.88M
Growth (%)-+593.79%+0.22%+5.29%+9.33%-13.28%-7.61%+3.26%+41.23%+53.59%+51.96%+52.16%+70.99%+35.63%-30.04%-58.41%+56.64%+20.47%+66.62%+89.43%+28.29%+19.80%
Cost of Revenue12.20K135.02K72.59K656.10K338.28K256.46K492.09K344.76K1.19M5.79M6.45M6.91M10.10M10.20M11.65M11.93M10.42M11.68M17.84M26.26M34.91M43.43M
Gross Profit513.77K3.51M3.58M3.19M3.87M3.39M2.88M3.14M3.72M1.76M5.03M10.56M19.76M30.30M16.69M-144.00K8.04M10.56M19.22M43.93M55.14M64.44M
Gross Margin97.68%96.30%98.02%82.96%91.96%92.97%85.41%90.10%75.72%23.31%43.78%60.47%66.17%74.81%58.88%-1.22%43.58%47.50%51.87%62.58%61.23%59.74%
Operating Expense7.63M8.65M13.93M19.19M19.64M24.50M14.01M12.34M15.50M17.83M20.37M24.94M32.61M42.58M48.78M43.02M35.17M37.41M57.12M71.26M79.86M79.84M
Operating Income-7.12M-5.14M-10.35M-16.00M-15.77M-21.11M-11.13M-9.20M-11.78M-16.07M-15.34M-14.38M-12.85M-12.27M-32.10M-43.17M-27.12M-26.84M-37.90M-27.33M-24.72M-15.40M
Operating Margin-1353.61%-140.80%-283.00%-415.41%-374.54%-578.14%-329.89%-264.12%-239.50%-212.75%-133.65%-82.34%-43.01%-30.30%-113.27%-366.30%-146.93%-120.69%-102.28%-38.93%-27.45%-14.28%
EBITDA-6.86M-4.93M-8.77M-12.86M-13.43M-16.66M-10.37M-9.22M-9.80M-15.59M-14.88M-13.50M-11.57M-10.19M-29.47M-39.74M-23.98M-24.09M-36.39M-30.47M-22.02M-14.01M
EBITDA Margin-1304.64%-135.09%-239.77%-333.87%-319.05%-456.41%-307.41%-264.84%-199.19%-206.42%-129.58%-77.29%-38.73%-25.15%-104.00%-337.23%-129.90%-108.33%-98.21%-43.41%-24.45%-12.98%
Net Income-7.04M-5.07M-9.72M-14.54M-14.19M-20.49M-10.98M-9.00M-11.87M-16.18M-15.26M-14.47M-13.17M-12.29M-32.45M-43.10M-28.66M-29.00M-44.04M-43.10M-38.07M-33.52M
Net Income Margin-1338.66%-138.98%-265.90%-377.70%-337.04%-561.26%-325.43%-258.54%-241.36%-214.12%-132.90%-82.86%-44.11%-30.33%-114.51%-365.72%-155.27%-130.41%-118.86%-61.40%-42.28%-31.07%
R&D6.23M6.85M11.41M15.60M15.31M18.75M9.06M6.23M3.29M1.58M742.00K2.10M332.00K1.83M1.81M9.00M4.54M5.59M7.56M6.38M10.55M10.35M
R&D as % of Total Revenue1184.54%187.73%312.09%405.11%363.72%513.70%268.61%178.82%66.95%20.88%6.46%12.03%1.11%4.51%6.39%76.34%24.61%25.13%20.39%9.08%11.72%9.59%
Interest Expense214.19K210.82K1.11M1.61M12.53K28.65K113.05K82.95K357.08K20.00K23.00K99.00K436.00K122.00K82.00K516.00K1.54M1.88M2.74M5.77M7.63M12.16M
Interest Expense % of Total Revenue40.72%5.78%30.39%41.73%0.30%0.78%3.35%2.38%7.26%0.26%0.20%0.57%1.46%0.30%0.29%4.38%8.36%8.43%7.40%8.22%8.47%11.27%

Balance Sheet

Currency: USD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets8.76M16.81M48.54M58.18M54.36M35.46M19.18M19.04M20.00M29.38M30.95M57.74M67.72M58.52M65.48M40.63M31.86M75.07M119.14M129.13M157.33M147.95M
Total Liabilities1.72M4.86M6.33M8.43M8.92M8.53M4.92M4.37M3.98M4.85M7.18M13.48M14.98M14.97M13.36M20.90M26.01M28.17M109.82M121.92M142.49M160.05M
Total Equity7.04M11.95M42.21M49.75M45.44M26.94M14.26M14.67M16.02M24.54M23.78M44.26M52.74M43.55M52.12M19.72M5.85M46.90M9.31M7.21M14.84M-12.09M
Cash310.43K11.16M43.30M48.26M42.60M25.84M14.09M14.42M15.49M24.68M18.90M30.52M30.51M16.83M26.20M22.05M15.95M58.50M15.50M22.38M46.80M29.03M
Total Debt29.82K15.40K6.60K4.37K1.39K-5.32K207.37K1.43M--848.00K538.00K884.00K526.00K11.00M15.87M15.56M39.79M41.27M60.06M95.11M
Net Debt-280.61K-11.14M-43.29M-48.26M-42.60M-25.84M-14.08M-14.21M-14.06M-24.68M-18.90M-29.67M-29.97M-15.94M-25.68M-11.05M-82.00K-42.94M24.29M18.89M13.27M66.08M

Cash Flow

Currency: USD2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-6.14M-4.85M-6.84M-16.48M-12.96M-18.34M-10.81M-8.50M-11.25M-14.11M-18.51M-14.39M-16.59M-10.49M-28.54M-22.29M-20.24M-22.55M-34.12M-21.50M-18.53M-10.42M
Investing Cash Flow-1.12M5.11M-729.85K400.95K-2.25M169.06K912.36K-279.96K-526.36K-1.25M-1.26M-7.58M-5.32M-6.05M-1.34M-73.00K-537.00K-885.00K-29.04M-3.93M-1.64M-20.06M
Financing Cash Flow6.36M10.65M38.44M16.44M11.80M156.17K09.47M12.76M24.28M14.67M35.04M21.09M573.00K41.67M17.96M14.29M66.50M20.72M32.28M44.60M12.70M
Capital Expenditure427.01K216.75K1.38M1.05M3.14M424.09K94.43K474.37K642.74K1.22M1.34M2.10M4.88M4.86M1.34M73.00K537.00K896.00K4.16M5.02M2.16M1.16M
Free Cash Flow-6.56M-5.07M-8.22M-17.53M-16.11M-18.76M-10.91M-8.98M-11.89M-15.32M-19.86M-16.50M-21.47M-15.35M-29.89M-22.36M-20.78M-23.44M-38.28M-26.52M-20.69M-11.57M
Dividends Paid---------------0000000
FCF to OCF106.96%104.47%120.17%106.39%124.22%102.31%100.87%105.58%105.71%108.63%107.25%114.60%129.45%146.33%104.71%100.33%102.65%103.97%112.20%123.35%111.65%111.11%
Dividend Paid to FCF---------------0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Earnings

Report DateDec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Aug 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 29, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Nov 5, 2021Mar 2, 2022Apr 27, 2022Aug 26, 2022Oct 27, 2022Mar 9, 2023May 15, 2023Aug 23, 2023Nov 8, 2023Mar 6, 2024May 1, 2024Aug 21, 2024Nov 6, 2024Feb 26, 2025May 14, 2025Aug 14, 2025Nov 12, 2025Feb 26, 2026May 13, 2026Aug 13, 2026Nov 11, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-1.700.000.000.000.000.000.000.00-1.600.000.000.00-0.60-0.47-0.53-0.60-0.53-0.65-0.40-0.22-0.19-0.25-0.30-0.26-0.25-0.19-0.13-0.12-0.11-0.13-0.15-0.12-0.07
EPS Actual-0.17-0.15-0.14-0.12-0.12-0.11-0.11-0.16-0.16-0.12-0.12-0.10-0.10-0.06-0.06-0.12-0.12-0.09-0.09-0.06-0.060.010.01-0.13-0.13-0.14-0.14-0.80-0.15-0.12-0.12-0.22-0.22-0.09-0.09-0.60-0.08-0.06-0.06-4.50-0.88-0.50-0.70-0.50-1.10-0.50-0.30-0.40-0.39-0.31-0.31-0.40-0.14-0.19-0.14-0.16-0.17-0.17-0.18-
Surprise---------------------------52.94%-------62.50%----650.00%-87.23%5.66%-16.67%5.66%-69.23%-25.00%-36.36%-110.53%-56.00%-3.33%-19.23%-60.00%26.32%-46.15%-16.67%-45.45%-30.77%-13.33%-50.00%-
Timing---------------------------Pre-market-------After-hours---After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-

Key Statistics & Ratios

Market Cap53.93M
Enterprise Value143.88M
Trailing P/E0.00
Forward P/E27.70
Price / Sales0.47
Price / Book23.64
EPS-0.71
Book Value-0.592
Revenue (TTM)114.02M
Gross Profit (TTM)71.67M
EBITDA-14.93M
Profit Margin-32.74%
Operating Margin-18.74%
Return on Equity-2440.41%
Return on Assets-9.83%
Shares Outstanding95.42M
Shares Float42.51M
Beta-501643.70
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 6 analystsTarget 1.80
  • Strong Buy
    5
  • Buy
    1

Ownership Breakdown

Institutions
45.15%
Insiders
22.14%
Retail / Other
32.71%

Top Institutional Holders

  • Rhumbline Advisers
    00.00%

Top Fund Holders

  • Hood River Small/Mid-Cap Growth
    154.18K0.56%
  • Hood River Small/Mid Cap Gr CITFounder's
    154.18K0.56%
  • Pleiades Small Cap Equity A
    84.49K0.31%
  • Hood River International Opp Instl
    45.40K0.17%
  • Perkins Discovery
    35.00K0.13%
  • Fidelity® NASDAQ Composite Index®
    2.88K0.01%

Stock Splits

  • Nov 14, 20231:10